Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
NCT00000433
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
NIH
Sponsor class
Conditions
Spondylitis, Ankylosing
Interventions
DRUG:
Anti-Tumor Necrosis Factor
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)